NewAmsterdam Pharma Company N.V. - Warrant — Cash Flow (NASDAQ:NAMSW)

Financials

Cash from operating activities —-141.22 M-158.56 M-147.78 M -147.78 M Cash from investing activities —-24 K-62.85 M-174.92 M -174.92 M Cash from financing activities —8.91 M659.51 M29.52 M 29.52 M Free cash flow —-141.24 M-159.24 M-148.03 M -148.03 M

NAMSW

Financials

Haberler

AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights

NewAmsterdam: Obicetrapib MAA Filings Merit Continued 'Buy' Rating (NASDAQ:NAMS)

abrdn Life Sciences Investors Q1 2025 Commentary

abrdn World Healthcare Fund Q4 2024 Commentary (NYSE:THW)